ENTITY

Ainos (AIMD US)

27
Analysis
Health Care • United States
Ainos, Inc. is a diversified healthcare company. The Company engages in the discovery and development of novel biopharmaceuticals, technologically medical treatments, and consumer products, as well as provides treatments of neoplastic, viral, and autoimmune diseases. Ainos operates in the United States and Taiwan.
more
bullish•Ainos
•14 May 2025 20:41•Issuer-paid

Ainos, Inc: 1Q25 Earnings Update; Building Up AI Nose Revenue

1Q25 revenue reflects AI Nose sales. Ainos reported $106K in 1Q25 revenue, reflecting 412% Y/Y growth from $21K in 1Q24.

Logo
165 Views
Share
bullish•Ainos
•23 Apr 2025 04:56•Issuer-paid

Ainos, Inc: Ugo Robotics Partnership Moving Rapidly with AI Nose Installed

Ainos and partner ugo completed the installation of AI Nose on a humanoid service robot, enhancing the functional applications of ugo’s robotics...

Logo
304 Views
Share
bullish•Ainos
•11 Apr 2025 19:39•Issuer-paid

AIMD: Deep Dive into AI-Powered Smell in Semi Fabs and Robotics After Recent Partnerships

Ainos recently entered partnerships with ugo and ASE, expanding AI Nose development to robotics and industrial applications.

Logo
434 Views
Share
bullish•Ainos
•13 Mar 2025 06:30•Issuer-paid

Ainos, Inc: ASE Collaboration Expands AI Nose Opportunity in Smart Manufacturing

Ainos entered a strategic collaboration with Advanced Semiconductor Engineering (ASE) to integrate AI Nose into ASE’s semiconductor packaging and...

Logo
184 Views
Share
bullish•Ainos
•11 Mar 2025 04:17•Issuer-paid

Ainos, Inc - Partners AI Nose to Give Robots the Ability to Smell

Under the collaboration, the AI Nose technology will be licensed to ugo, with the companies working together to design and validate AI Nose-enabled...

Logo
257 Views
Share
x